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There has been considerable interest in the ways in which
inheritance might contribute to susceptibility of nephritis since
the earliest attempts to understand its pathogenesis. This was
first expressed by Wells [1] in 1812, who observed that the
siblings of a child who developed nephritis after scarlet fever
were much more likely to develop nephritis than were the
siblings of children who developed scarletina without nephritis.
He attributed this as being "due in part, to a similarity of
constitution derived from both parents." The familial pre-
disposition to post-streptococcal nephritis has since been con-
firmed many times, and extended to other types of human
glomerular disease. Unfortunately, attempts to explain the
reasons have generally been unsatisfactory as this would re-
quire a full understanding of the pathogenesis of nephritis. Over
the past decade, the considerable advances in the understand-
ing of the immune system more generally now make it possible
to ask precise questions about the processes responsible for
nephritis, and to identify genes that influence susceptibility.
Most, if not all types of nephritis are caused by local immune
responses within the glomerulus. Some of the antigens involved
are intrinsic and thus the subject of autoimmune attack, while
others are extrinsic and planted within the glomerulus, either
because of an affinity of the antigen for glomerular structures,
or because they have been deposited in an immune complex.
Chronic inflammation requires a continuing immune response
which implies the existence either of an autoimmune reaction or
else of persistent antigenic challenge. Binding of specific anti-
body or T cell to an antigen is only the first step in an
immunologically-mediated inflammatory response and its prin-
ciple function is as a focus for non-specific cellular and humoral
inflammatory mediators. The acute inflammation is eventually
replaced by more chronic processes which may result in pro-
gressive scarring. It follows that inherited differences that
influence specific immune responses, acute inflammation, and
scarring could all effect the susceptibility to glomerulonephritis,
and there is evidence for inherited differences in each of these
processes, at least in rodents.
Inherited differences in immune responses
The immune system almost always reacts strongly to foreign
antigens, but rarely to self-antigens because potentially harmful
responses are inactivated or eliminated during otogeny. The
trimolecular complex of major histocompatibility complex mol-
ecule (MHC), antigen derived peptide and T cell receptor is the
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central element in an immune response. It is brought about in
three stages: (i) digestion of antigen by antigen presenting cells
(APC) to peptides [2]; (ii) binding of suitable peptides to nascent
MHC molecules which are then expressed on the cell surface
[21; and (iii) recognition of MHC/peptides complex by antigen
receptors on T cells (TcR) [3]. Binding of TcR to the MHC/
peptide complex initiates a set of events that depend on the
context in which the reaction occurs. During ontogeny, the
affinity of the interaction between T cell and MHC/peptide
determines whether a T cell clone is destroyed by apoptosis
(programmed cell death) or expanded [4]. Thus, variation in the
affinity of binding has an important influence on the editing
(censoring) of the T cell repertoire, and could be influenced by
allelic variation of either partner. The T cell responses also
depend on the co-stimulatory signals delivered by the antigen
presenting cell, which detennine whether peripheral T cells are
activated (allergized) or inactivated (annergized) after ligation
of their receptors [5], a process critical to the maintenance of
tolerance to self-antigens. Finally, the cytokine environment
profoundly effects the type of response that occurs. T cells
developing in the presence of interferon-y (IFN-y), interleu-
kin-2 and interleukin-12 differentiate into T helper cells (often
called Thl) that themselves secrete IL-2, interferon-)' and
lymphotoxin (TNF-f3) and facilitate delayed hypersensitivity
responses [6, 7]. In contrast, those exposed to interleukin-4 and
interleukin-13 during development mature into interleukin-4,
interleukin-5 and interleukin-l3 producing cells (Th2) that pro-
mote antibody-mediated responses [6, 7]. Thi and Th2 cells
were first observed in vitro, but have now been demonstrated in
vivo and the propensity to produce Thi and Th2 responses has
been shown to be genetically controlled [8, 9]. This has an
important influence on the susceptibility to infection [8] and for
the development of autoimmune disease [9]. For example,
susceptibility to Leishmania infection is genetically determined
in this way. When inoculated with Leishmania, CBA mice
produce predominantly Th2 responses and die of uncontrolled
infection whereas C57 black mice produce predominantly Thi
responses and survive [8]. Susceptible mice can be made
resistant, either by administering INF-y or by passive immuni-
zation against IL-4 [10]. Susceptibility to adjuvant arthritis,
diabetes in NOD mice and autoimmune allergic encephalomy-
elitis (EAG) all appear to be determined by the balance between
Thi and Th2 cells, but comparable studies have not been
performed in experimental glomerulonephritis. However, it
should be noted that BN rats which are susceptible to anti-GBM
disease make predominantly Th2 responses when injected with
mercuric chloride [11]. It is not clear what determines the
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tendency to make Thi or Th2 responses, but three potential
influences have been identified: (i) inheritance of particular
MHC alleles, as exemplified by studies of the munne response
to a peptide derived from human type IV collagen (presentation
by H2s results in a Thi response while presentation by H2td
results in a Th2 response) [12]; (ii) a genetic locus on chromo-
some 1 in mice which determines the capacity of macrophages
to produce factors that stimulate NK cells to synthesize IFN7
[13] and which protects against intracellular parasites [reviewed
in 14]; and (iii) the genetically determined magnitude of the
stress response in which mice that produce large quantities of
corticosteroids in response to stress develop Th2 responses,
while low responders develop Thi responses [15, 16].
Inherited differences in the magnitude of immune responses
were explored many years ago by Biozzi and his colleagues
using classical breeding techniques [reviewed in 17]. They first
used repeated brother/sister matings to produce strains of mice
that had high or low antibody responses; later a similar ap-
proach was used to produce strains that produced high or low
cell-mediated responses [17]. It was estimated that between 10
and 18 genes were responsible for the variation, and that allelic
differences at the MHC locus were important, Biozzi mice have
not been used for studies of experimental nephritis but Steward,
Reinhardt and Staines, who used to same technique to produce
strains of mice that differed in affinity of antibody responses [18]
showed that low affinity mice were much more susceptible to
chronic serum sickness than were the high affinity mice [19].
This is an excellent example of the way in which antigen
independent differences in immune responsiveness influence
susceptibility to nephritis, and suggests the need for investiga-
tion of the effects of other inherited differences on glomerular
disease.
Experimental models of autoimmune glomerulonephritis
Studies of autoimmunity in experimental nephritis can pro-
vide insights into their human counterparts. In some models,
autoimmunity is restricted to a single antigen as is the case in
anti-GBM disease and in Heymann nephritis. In other situa-
tions, it is part of a generalized loss of tolerance to self antigens,
as for example in lupus prone strains of mice.
Druet and his colleagues used classical [20] genetic tech-
niques to analyze the role of the MHC complex in susceptibility
to mercuric chloride induced anti-GBM disease in Brown
Norway rats. All the Fl progeny of BN (susceptible) x Lewis
(resistant) rats developed anti-GBM antibodies when treated
with mercuric chloride, whereas this only happened to a pro-
portion of the Fl backcross or F2 generations. None of the rats
who were homozygous for the Lewis MHC developed anti-
GBM disease, whereas one-half to two-thirds of rats heterozy-
gous or homozygous for the Brown Norway MHC did develop
it. These data show first that susceptibility to anti-GBM disease
in this model is linked to the BN MHC, and second that genes
at other unlinked loci are required. The number of additional
genes required can be estimated from the proportion of affected
to unaffected rats, and the results suggested the involvement of
genes at one or two other loci. Linkage of the Lewis MHC to
Heymann nephritis was demonstrated by Steinglen, Thoenes
and Gunther [21] using a broadly similar approach. Thus, both
organ specific models of autoimmune glomerulonephritis in rats
are linked to the MHC, a finding which has obvious implications
for glomerulonephritis in humans.
Experimental models of generalized autoimmunity
Allelic variation in the MHC also appears to be involved in
the development of autoimmune lupus strains of mice, albeit in
the more generalized loss of tolerance to self-antigens. A
variety of strains of lupus prone mice have been developed of
which NZB/NZW and MRL/lpr have been studied most thor-
oughly [reviewed in 22]. The NZB/NZW strain was raised in the
l950s and has many of the familiar features of lupus. There is
polyclonal B cell activation which results in hyperglobulinemia
and synthesis of a range of autoantibodies, including those to
single and double stranded DNA. Clinically the mice have a
high incidence of autoimmune hemolytic anemia, and develop
glomerulonephntis which is morphologically similar to lupus
nephntis; NZB/NZW mice usually die from renal failure. MRL/
lpr mice also develop a polyclonal B cell activation with
antibodies to DNA and nephritis. The lpr mutation, however,
results in widespread lymphadenopathy which is only associ-
ated with lupus in mice with the MRL background. The genetics
of both strains have been analyzed in detail using a mixture of
classical and molecular techniques.
NZB/NZW mice
MHC genes and those encoding the TcR have both been
implicated in the susceptibility to autoimmunity in NZB/NZW
mice. Genes from each parent are needed because the disease is
found in Fl mice and not in the parental strains. A number of
studies have implicated MHC genes from both strains in the
development of the disease [23—26]. Back cross analysis using
NZB x (NZBxNZW) Fl mice has demonstrated a strong but
imperfect correlation between the NZB MHC haplotype H2z
and the presence of autoantibodies and the renal disease [24];
subsequent studies have shown the results cannot be explained
by linkage to genes at adjacent loci [25]. Similar data have been
presented for NZB x SWR mice which also develop lupus [26].
Thus it seems likely that NZW MHC class II molecules (IAz or
IEz) are responsible for the effects.
The importance of the MHC class II genes in determining
susceptibility to lupus in NZB mice has been confirmed in
studies using congenic animals in which different class II alleles
are added to the NZB background. These show that the
introduction of the H2" haplotype has little effect, whereas mice
in whom H2ml2 is introduced behave like NZB/NZW Fl mice
in that they develop anti-DNA antibodies and severe renal
disease [27, 28]. The sole difference between the H2" and the
H2bm12 haplotypes lies in the MHC class II I-Af3 chain which
has substitutions at three critical residues [27]. These studies
again suggest that both NZB and NZW MHC are important for
autoimmunity, and Schwartz and his colleagues have analyzed
this phenomon in detail [reviewed in 29]. They suggest that the
critical event is the formation of a hybrid class II molecule with
an a-chain from one of the parental strains coupled with /3-chain
from the other. There is evidence for the existence of such
hybrid class II molecules, but none for their involvement in the
autoimmune process. In fact, some evidence to the contrary
can be derived from so-called "New Zealand mixed" strains of
mice produced by Rudofsky et al [30] from brother/sister
matings from F2 NZB/NZW mice bred for the severity of the
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Table 1. Genetic markers linked to glomerulonephritis in MRL mice
Chromosome Lod score Marker
7 3.0 Pkcg-otf
12 3.9 Dl2Nyu3-Dl2Sell
19 17.04 Fas
Data from Watson et al, J Exp Med 176:1645—1656, 1992 [36]. Used
with permission.
nephntis. Twelve of these strains have been analyzed in detail
and have an incidence of nephntis that varies from 0 to 89%.
These strains have yet to be analyzed in detail, but it is already
known that the nephritic strains are homozygous for the NZW
H2, and tantalizingly most are also CS deficient.
NZB mice also have a major deletion in the genes that encode
the T cell receptor [31—33]. The deletion spans the region from
the C131 to the Jf32 loci and probably has functionally important
consequences, not least because SWR mice which also produce
lupus prone offspring when mated with NZW mice have a
similar deletion. Thus, it seems probable that MHC and T cell
receptor genes are both involved in the development of the
lupus syndrome.
MRL/lpr mice
Much of the recent analysis of this strain has focused on the
nature of the lpr mutation because of its role in producing the
lupus syndrome in MRL mice [34]. Watanabe-Fukanaga et al
[35] have recently shown that the lpr phenotype is due to a
mutation in the second intron of the Fas gene and that it limits
its expression. The Fas protein is a surface receptor found on B
and T lymphocytes which initiates apoptosis, and so could be
crucial for the negative selection of the T cells in the thymus
during otongeny (that is, for editing the T cell repertoire). The
importance of this mutation for the development of autoimmu-
nity in MRL mice has been demonstrated by linkage studies
[36], and corroborative evidence for its importance comes from
three other sources: a second mutation of the Fas gene (lpr cg)
causes a point mutation in the Fas protein and is similarly
associated with lupus [37]; a mutation in the gid gene which is
thought to encode the ligand for Fas is likewise associated with
lupus [38, 39]; and finally overexpression of Bcl-2 which is an
oncogene which confers resistance to apoptosis is also associ-
ated with lupus [40]. Thus, it appears that failure to eliminate
potentially autoreactive T cells and B cells by apoptosis causes
lupus in MRL mice, but it is apparent that full expression of the
syndrome requires contributions of other genes from the MRL
background. Recent linkage studies by Watson et al [36] have
identified genes on chromosome 7 and chromosome 12 that are
strongly associated with a pre-disposition to severe nephritis in
MRL/lpr mice and other manifestations of lupus (Table 1).
Kinjoh, Kyogoku and Good [41] have provided further evi-
dence for an inherited susceptibility to glomerulonephritis in the
MRL background. They developed strains of mice derived from
bother/sister matings of MRL/lpr and BXSB/lpr mice that
spontaneously develop crescentic nephritis but not anti-DNA
antibodies. Analysis of these mice shows that they are homozy-
gous for the MRL MHC. Thus, it appears that the interactions
of genes at a number of different loci are responsible for the
Table 2. HLA class II associations with glomeruonephritis,
established by serological techniques
Caucasoi
Specificity
ds
RR
Japanese
Specificity RR
Goodpasture's syndrome DR2(w15) 10.5 — —
Membranous nephropathy DR3 5.6 DR2(wl5) 6.8
Mesangial IgA disease None DR4 2.6
Minimal change nephrotic DR7 5.8 DR8 10.1
syndrome
Penicillamine DR3 —
nephropathy
Gold nephropathy DR3 —
See references 42 and 43 for full data.
susceptibility to autoimmunity and to the
nephritis in MRL/lpr mice.
MHC in human glomerulonephritis
development of
The data from the studies of experimental glomerulonephritis
suggest that MHC is involved in both organ specific and
generalized autoimmunity. This provides strong justification for
the detailed examination of the HLA complex in humans with
glomerular disease. Early studies using serological techniques
to examine the HLA class II region showed strong positive
associations between particular HLA molecules and various
types of nephritis in Caucasoid populations (Table 2), such as
anti-GBM disease, membranous nephropathy, minimal change
nephrotic syndrome in children and the susceptibility to nephri-
tis after exposure to gold or penicillamine [reviewed in 42, 43].
Similar studies in Japanese populations revealed equally strong
but different associations [42, 43]. This provides strong evi-
dence for the involvement of HLA genes in nephritis, but there
are huge problems in interpreting the data. The original meth-
ods lacked precision, and identified broad HLA specificities
rather than individual DR alleles. They were unable to distin-
guish between effects at the different class II loci (DR, DP and
DQ). Furthermore, they were conducted against a background
of uncertainty of the structure functional relationships of HLA
molecules, and profound ignorance of the immunopathogenesis
of nephritis.
The development of molecular techniques for examining the
HLA complex has enabled more recent studies to be conducted
with much more precision [44, 45], and there is now a broad
understanding of how HLA molecules present peptides to T
cells. This is based on the definition of HLA class I [46] and
class II [47] molecules to atomic resolution by crystallography,
and a knowledge of the characteristics of naturally processed
peptides that can be eluted from them [48—50]. Class II mole-
cules bind peptides of 12—22 residues in length and peptide
specificity is determined by four clusters of allelic residues on
the HLA molecule [47]. Peptide motifs that preferentially
associate with particular DR molecules have been identified [50]
and can be related to presentation of particular antigens.
Anti-GBM disease
Anti-GBM disease provides the best human model of nephri-
tis with which to assess the power of these new approaches
because its immunopathogenesis is known [reviewed in 51]. It is
caused by autoimmunity to the GBM, and characterized by
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Table 3. HLA-DR specificities in 69 patients with anti-GBM disease
typed by RFLP
Patients %(N = 69)
Controls %
(N = 1103) P
DRI 7.2 20.7 6.5 <0.01
DR2 (DRw15) 79.7 31.2 65.6 <0.0001
DR3 15.9 21.8
DR4 47.8 36.9 2.8 <0.09
DR5 10.1 12.7
DR6 13,0 25.3
DR7 8.7 24.1 7.7 <0.006
DR8 2.9 5.4
DR9 1.4 2.1
DRIO 2.9 1.4
anti-GBM antibodies that bind to the NC! domain of the 3
chain of type IV collagen (a3(IV)NC1) [52], the gene for which
has been cloned [53]. Thus, it is a disease caused by autoim-
munity to an extracellular protein whose amino acid sequence is
known. We originally described an association with HLA-DR 2
[54, 55] and have now re-examined it using the molecular
techniques on a new set of 69 Caucosoid patients. The results
confirm the greatly increased frequency of alleles that com-
prised the DR2 specificity, and show that the association is due
entirely to DRw15 alleles which were present in 80% of patients
compared with 31% of controls, relative risk 9.6 (Table 3).
Further analysis using sequence specific oligonucleotide (SSO)
typing to determine which DRwl5 alleles were involved showed
that the increased frequency was due predominantly to the
B1*1501 allele, but that the frequency of the much rarer
Bl*1502 was also increased. Nucleotide sequencing in two
patients confirmed the derived amino acid sequences of the
1501 allele was identical to that previously published. Thus,
Goodpasture's syndrome is associated with inheritance of HLA
haplotypes containing normal Bl*1501 and 1502 alleles.
DRB *1501 is in very strong linkage disequillibriurn with the
DRBS*0101, DQA*0102 and DQB*602 alleles and so potentially
these or other unidentified genes linked to the 1501 allele could
be involved in susceptibility.
The greatly increased frequency of DRw15 should mean that
the frequency of all other specificities should be decreased, but
this is not the case (Table 3). The frequency of DR4 was greater
in patients than in controls (48% compared to 37%) and the
difference was more obvious in patients who had not inherited
DRw1S. In retrospect the frequency of DR4 had also been
increased in our original series of 38 patients, but this was not
appreciated at the time because of the difficulty of separating
DR4 from DR7 serologically [54, 55]. Overall, 94% of the
patients inherited DRw15 or DR4 or both. The increased
frequency of DRw15 and DR4 contrasted with those of DR1 and
DR7, both of which were significantly less common in patients
compared with controls. This suggests that haplotypes bearing
the DR1 and DR7 alleles confer protection against Goodpas-
ture's syndrome. Thus, DR genes at four different HLA haplo-
types appear to influence susceptibility which is a situation
analogous to that of other autoimmune diseases [45].
Recent studies have emphasized the importance of specific
cassettes of amino acids in determining susceptibility to certain
diseases, notably rheumatoid arthritis and coeliac disease [45].
Comparison of the amino acid sequence of DQ alleles expressed
by the four haplotypes relevant to Goodpasture's syndrome
revealed no striking similarities. Only five of the amino acids at
the 16 polymorphic residues in the f31 domain of the DR
molecule are common to DRw15 and DR4 alleles, four of which
are located in a cassette of six amino acids between position 26
and 31. This suggests a possible role for the cassette in the
development of the anti-GBM response, and the hypothesis is
supported by studies of DR1 and DR7 which are strikingly
different in the relevant region. Polymorphic amino acids of
MHC molecules face the antigen binding groove and it is easy to
envisage how they might influence antigen presentation and so
determine susceptibility to autoimmune disease. This hypothe-
sis should be testable in vitro now that the a3(IV)NC1 gene has
been cloned and expressed as a recombinant protein [53].
Membranous nephropathy
There are no other types of primary nephritis known to be
caused by autoimmunity but membranous nephropathy is an
obvious candidate by analogy to Heymann nephritis. Numerous
studies have shown a strong association with HLA-DR3 in
Caucasoids [42, 43, 56], and with DR2 in Japanese [57, 58]. The
molecular approach has been used to examine the disease
which is associated with different specificities in different pop-
ulations [58—61]. These studies confirm the association is with
haplotypes bearing the B 1*0301 allele in Caucasoids and the
B1*150l in Japanese, but unfortunately have not resolved why
they should be different. Specifically the suggestion that the
primary association in membranous nephropathy was with a
null allele in the complement C4 locus has been refuted.
IgA nephropathy
Transracial studies have also been used to examine the HLA
association in IgA nephropathy. Serological techniques had
previously established a consistent association between HLA-
DR4 in Japanese, whereas there has been no consistent asso-
ciation in European or North American Caucasoids [42, 43].
Two recent studies in British Caucasoids have suggested that
IgA nephropathy is significantly associated with alleles at the
DQB locus [62, 63]. Specificially, Li et al reported that IgA
nephropathy was associated with an increased frequency of the
DQB*030l alleles (formally called DQw7) which was present in
71% of patients compared to 28% of controls (relative risk 6.2)
[63]. DQB*030l is in linkage disequilibrium with DR4 and DR5
in Caucasoid populations and the frequencies of both were
increased. This allele is uncommon in Japanese but also in
linkage disequilibrium with DR4. Much more commonly, how-
ever, they have BQ*0401 which differs from BQ*0301 at only
four amino acids and is found almost exclusively in Japanese
populations. Thus, it is possible that the DR association in
Japanese could reflect a primary association with alleles at a DQ
locus. Preliminary evidence from our laboratory suggesting an
increased frequency of the DR4, DQB*030l in haplotype in
both Japanese and Caucasoids and from Hiki et al [64] suggest-
ing an association with DQW4 and from Ogahara et a! [60] who
reported an increased frequency of DQA1 *0301, all support this
possibility. There is also a report suggesting a role for the DR4,
DQB*0301 haplotye in a Chinese kindred with familial IgA
disease [65]. However, more extensive comparisons will need
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Table 4. DQw7 haplotype frequencies in patients with systemic
vasculitis
Haplotypes
Patie
N = 58
nts
%
Controls
N = 1103 % y P
DR4,DQw7 18 31 149 13 14.2 .0004
DRS,DQw7 10 17 142 12 0.9 .45
DR6,DQw7 4 6.9 23 2 5.6 .05
Data from Spencer et al, Kidney mt 41:1059—1063, 1992 [67]. Used
with permission.
to be made. Moore et a! failed to find a DP association in three
different groups of European Caucasoids [66].
Systemic vasculitis
The recognition that autoimmunity to neutrophil cytoplasmic
antigens may be involved in the pathogenesis of systemic
vasculitis has led to a re-examination of the possible involve-
ment of the MHC in these diseases. We recently examined the
HLA complex in a group of 59 patients with vasculitis, 34 with
Wegener's granulomatosis, 25 with microscopic polyarteritis
and three of whom had isolated rapidly progressive glomerulo-
nephritis [67]. The DQw7 (DQB*0301) allele was significantly
more common in the patients (53%) compared with the controls
(27.8%) ( 17,8 relative risk 2.9) and all the common Caucasoid
haplotypes bearing this allele were present. Comparison of the
frequencies of the haplotypes showed that the strongest asso-
ciation was with the DR4 DQw7 haplotype (Table 4) [67],
irrespective of whether the diagnosis was Wegener's granulo-
matosis or microscopic polyarteritis, and of the specificity of
the ANCA. This is surprising, and clearly the data will need to
be confirmed.
The second observation was that the frequency of the DR3
(DRB 1*0301, DQA*0501, DQB*0201) haplotype was signifi-
cantly less common in patients (6.8%) than in controls (21.8%)
= 6.7). Similar data have recently been reported in an
abstract in a small group of patients with microscopic poly-
arteritis [68]. Thus, it is possible that this haplotype protects
against the development of vasculitis. Finally, patients with
persistent ANCA and repeated relapses had a significantly
greater frequency of haplotypes bearing DRwlS than those in
whom the ANCA rapidly became undetectable. This observa-
tion may help to explain discrepancies with earlier studies of
patients with rapidly progressive nephritis, considered by many
to be a limited expression of ANCA associated vasculitis.
Muller et al [69] have previously reported that idiopathic rapidly
progessive nephritis was associated with HLA-DR2 and with
the complement allotype BfFI, especially when they were
inherited together as part of an extended haplotype. None of the
patients was said to have evidence of systemic disease, which is
surprising in view of the high incidence of systemic symptoms
in most series of patients with RPGN. This was certainly the
case in a previous study of 45 patients who presented with
RPGN without anti-GBM antibodies [70]. The overall fre-
quency of DR2 was not increased, but when patients were
segregated into two groups depending on a diagnosis of Wegen-
er's granulomatosis (which tends to persist and relapse) or
microscopic polyarteritis (which is a much more common
disease), those with Wegener's had a significantly increased
frequency of DR2. It is much too early to draw firm conclusions
from studies of the HLA system in vasculitis, except to say that
it probably influences susceptibility.
Systemic lupus erythematosus
Unlike the murine counterparts, the Fas gene has not been
implicated in systemic lupus in humans, but a number of studies
have suggested involvement of the MHC. Initial serological
studies of HLA-DR specificities suggested that both DR2 and
DR3 were associated with the disease in Caucasoids [reviewed
in 71] and Chinese [72]. More recently molecular analyses of
patients with lupus have focused particularly on the associa-
tions between HLA-DQ polymorphisms and the development
of specific autoantibodies [72]. These studies have been re-
viewed by Arnet [73] who has suggested that heterozygosity at
DQ loci is important [74]. This is consistent with the hypothesis
developed in NZB/NZW mice but should for the moment be
regarded as speculative. It remains controversial whether the
results are due to the effects of HLA-class II molecules, or to
partial deficiency of C4 and C2 which are also located in the
MHC. There is no doubt that complete deficiencies of classical
pathway complement components greatly increase susceptibil-
ity for systemic lupus [reviewed in 75], and also of partial C2
deficiencies [76], but these account for only a tiny minority of
those suffering from the disease. A number of groups have
shown a markedly raised prevalence of C4aQO genes in pa-
tients with lupus [77—8 1]; however, this is usually part of a DR3
bearing haplotype in Caucasoids. Batchelor, Fielder and Wal-
port [82] reported an increased prevalence of C4aQO alleles
even in patients who were DR3 negative, and others have
reported an increased frequency of C4aQO in racial groups in
which this allele is unlinked to DR3 [72].
Conclusion
The available evidence demonstrates the important contribu-
tion of inheritance to the development of glomerulonephritis
experimentally, both in lupus strains of mice and in rats with
organ specific autoimmunity. There are now sufficient data from
nephritis clinically to implicate the HLA class II genes in
susceptibility, but it is also clear that genes at other loci will also
play a major role. Recent developments in molecular genetics
have extended greatly the techniques available for studying the
role of inheritance in multigenic diseases using a combination of
linkage studies using polymorphic markers and studies of
candidate genes. The application of this approach to patients
with glomerulonephntis should greatly clarify the present un-
certainties.
Reprint requests to Andrew J. Rees, M.D., Department of Nephrol-
ogy, Royal Postgraduate Medical School, Hammersmith Hospital,
London, W12 ONN England, United Kingdom.
References
1. WELLS WC: Observation on the dropsy which succeeds scarlet
fever. Trans Soc Improve Med Chir Know 13:167—186, 1812
2. GERMAIN RN, MARGULIES DH: The biochemistry and cell biology
of antigen processing and presentation. Annu Rev Immunol 11:403—
450, 1993
3. JORGENSEN JL, REAY PA, EHRICH EW, DAVIES MM: Molecular
components of T-cell recognition. Annu Rev Immunol 10:835—873,
1992
382 Rees: Immunogenetics
4. BLACKMAN M, KAPPLER J, MARRACK P: The role of the T cell
receptor in positive and negative selection of developing T cells.
Science 248:1335—1341, 1990
5. GIMMI CD, FREEMAN GJ, GRIBBXN JG, GRAY 0, NADEER LM:
Human T-cell clonal anergy is induced by antigen presentation in
the absence of B7 costimulation. Proc Nat! Acad Sci USA 90:6586—
6590, 1993
6. MOSMANN TR, CHERWINSKI H, BOND MW, GIEDLIN MA, C0FF-
MAN L: Two types of murine helper T cell clones. I. Definition
according to profile of lymphokine activities and secreted proteins.
(abstract) J Immuno! 136:2348, 1986
7. Scorr P: Selective differentiation of CD4+ T helper cell subsets.
Curr Opin Bk'! 5:391—397, 1993
8. Scorr P: IFN-y modulates the early development of Thi and Th2
responses in a murine model of cutaneous Leishmaniasis. J Immu-
no! 147:3149—3155, 1991
9. FOWELL D, MCKNIGHT AJ, POWRIE F, DYKE R, MASON D:
Subsets of CD4+ T cells and their roles in the induction and
prevention of autoimmunity. Immuno! Rev 123:37—64, 1991
10. CHATELAIN R, VARIKSLA K, COFFMAN RL: IL-4 induces a Th2
response in Leishmania major-infected mice, J Immuno! 148:1182—
1187, 1992
11. MATHIESON PW, THIRU S, OLIVEIRA DB: Regulatory role of 0X22
high T cells in mercury induced autoimmunity in the Brown
Norway rat. JExp Med 177:1309—1316, 1993
12. Muiu JS, PFEIFFER C, MADRI J, BOTTOMLY K: Major histo-
compatibility complex (MHC) control of CD4 T cell subset activa-
tion. II. A single peptide induces either humoral or cell-mediated
responses in mice of distinct MHC genotype. Eur J Immuno!
22:559—565, 1992
13. RAMARATHINAM L, NIESEL DW, KLIMPEL GR: Ity influences the
production of IFN-yby murine splenocytes stimulated in vitro with
Salmonella typhimurium. J Immunol 150:3965—3972, 1993
14. ScHUIU E, MALO D, RADZIOCH D, BUSCHMAN E, MORGAN L,
GROS P, SKAMENE E: Genetic control of innate resistance to
mycobacterial infections. Immunol Today 12:42—45, 1991
15. MASON D: Genetic variation in the stress response: susceptibility to
experimental allergic encephalomyelitis and implications for human
inflammatory disease. Immunol Today 12:57—60, 1991
16. MASON D: Role of the neuroendocrine system in determining
genetic susceptibility to allergic encephalomyelitis in the rat. Im-
muno!ogy 70:1—5, 1990
17. Biozzi G, MOUTON G, SANT'ANNA OA, PASSOS HC, CENNARI M,
REIs MH: Genetics of immunoresponsiveness to natural antigens in
the mouse. Curr Top Microbio! Immunol 85:31—98, 1980
18. STEWARD MR. REINHARDT MC, STAINES NA: The genetic control
of antibody affinity. Evidence from breeding studies with mice
selectively bred for either high or low affinity antibody production.
Immunology 37:697—702
19. DEVEY ME, STEWARD MW: The induction of chronic antigen-
antibody complex disease in selectively bred mice producing either
high or low affinity antibody to protein antigens. Immuno!ogy
41:303—311, 1980
20. DRUET E, SAPIN C, GUNTHER E, FEINGOLD N, DRUET P: Mercuric
chloride-induced anti-glomerular basement membrane antibodies in
the rat: Genetic control. Eur J Immunol 7:348—351, 1977
21. STEINGLEN B, THOENES GH, GUNTHER E: Genetic control of
susceptibility to autologous immune complex glomerulonephritis in
inbred rat strains. Clin Exp Immunol 33:88—94, 1978
22. DRAIn CG, KOTSIN BL: Genetic and immunological mechanisms
in the pathogenesis of systemic lupus erythematosus. Curr Opin
Biol 4:733—740, 1992
23. HIROSE S, UEDA G, Nooucui K, OKADA T, SEKIGAWA I, STAO H,
SHIRAI T: Requirement of H-2 heterozygosity for autoimmunity in
(NZBxNZW)Fl hybrid mice. EurJlmmunol 16:1631—1633, 1986
24. KOTZIN BL, PALMER F: The contribution of NZW genes to
lupus-like disease in (NZBxNZW)F1 mice. J Exp Med 165:1237—
1251, 1987
25. BABCOCK SK, APPEL YB, SCHIEFF M, PALMER E, K0TzIN BL:
Genetic analysis of the imperfect association of H-2 haplotype with
lupus-like autoimmune disease. Proc Nat! Acad Sci USA 86:7552—
7555, 1989
26. GHATAK S, SAINIS K, OWEN FL, DATFA SK: T-cell-receptor beta-
and I-A beta-chain genes of normal SWR mice are linked with the
development of lupus nephritis in NZBxSWR crosses, Proc Nat!
Acad Sci USA 84:6850—6853, 1987
27. CHIANG BL, BEARER E, ANSARI A, DORSHKIND K, GERSHWIN
ME: The BMI2 mutation and autoantibodies of dsDNA in NZB.H-
2bm12 mice. J Immuno! 145:94—101, 1990
28. MENGLE-GAW L, CONNER5 S, McDEvirr HO, FATHMAN CG:
Gene conversion between murine class II major histocompatibility
complex loci. Functions and molecular evidence from bm 12
mutant.JExp Med 160:1184—1194, 1984
29. NYGARD NR, MCCARTHY DM, SCHIFFENBAUER J, SCHWARTZ BD:
Mixed haplotypes and autoimmunity. Immuno! Today 14:53—56,
1993
30. RODOESKY UH, EVANS BD, BALABAN SL, MOTTIRONI VD, GAB-
RIELSEN AE: Differences in expression of lupus nephritis in New
Zealand mixed H2z homozygous inbred strains of mice derived
from New Zealand black and New Zealand white mice. Lab Invest
68:419—426, 1993
31. KOTZIN BL, BARR VL, PALMER E: A large deletion within the
T-cell receptor beta-chain gene complex in New Zealand white
mice. Science 229: 167—171, 1985
32. NOONAN DJ, KOFLER R, SINGER PA, CARDENAS 0, DixoN FJ,
THEOPHILOPOULOS AN: Delineation of a defect in T cell receptor /3
genes of NZW mice predisposed to autoimmunity. J Exp Med
163:644—653, 1986
33. BEHKLE MA, CHOU HS, HUPPIK, LOH DY: Murine T cell receptor
V/3 deletion mutants with deletions of /3 chain variable region
genes. Proc Nail Acad Sci USA 83:767—771, 1986
34. ANDREWS BS, EISENBER RA, THEOFILOPOULOS AM, IzuI S,
WILSON CB, MCCONAHEY PJ, MURPHY ED, ROTHS JB, DIxoN FJ:
Spontaneous murine lupus-like syndromes. Clinical and immuno-
pathological manifestations in several strains. J Exp Med 148:1198—
1215, 1978
35. WATANABE-FUKUNAGA R, BR.ANNAN CI, COPELAND NO, JENKINS
NA, NAGATA S: Lymphoproliferation disorder in mice explained
by defects in Fas antigen that medicates apoptosis. Nature 356:
314—317, 1992
36. WATSON ML, RA0 JK, GIKESON OS, RUIZ P, EICHER EM,
PESETSKY DS, MATSUZAWA A, ROCHELL JM, SELDIN MF: Genetic
analysis of MRL-!pr mice: Relationship of the Fas apoptosis gene
to disease manifestation and renal disease-modifying loci. J Exp
Med 176:1645—1656, 1992
37. MATSUZAWA A, MORIYAMA T, KANEKO T, TANAKA M, KIMURA
M, IKEDA Fl, KATAGIRI T: A new allele of the !pr locus, ipr, that
complements the gld gene in induction of lymphadenopathy in the
mouse. J Exp Med 171:519—531, 1990
38. COHEN PL, EISENBERG RA: Lpr and gld: Single gene models of
systemic autoimmunity and lymphoproliferative disease. Annu Rev
Immunol 9:243, 1991
39. DAVIDSON WF, DUMONT FJ, BEDIGIAN HG, FOWLKES BJ, MORSE
HC: Phenotypic, functional, and molecular genetic comparisons of
the abnormal lymphoid cells of C3H-lpr.lrp and C3H-g!d/gld mice.
J Immuno! 136:4075—4084, 1987
40. STRASSER A, WHITFINGHAM S, VAUX DL, BATH ML, ADAMS JM,
CORY 5, HARRIS AW: Enforced BCL2 expression in B lymphoid
cells prolongs antibody responses and elicits autoimmune disease.
Proc Nat! Acad Sci USA 88:8661—8665, 1991
41. KINJOH K, KYOGOKU M, GOOD RA: Genetic selection for crescent
formation yields mouse strain with rapidly progressive glomerulo-
nephritis and small vessel vasculitis. Proc NatI Acad Sci USA
90:3413—3417, 1993
42. REES AJ: The HLA complex and susceptibility to glomerulonephri-
tis. Plasma Ther 5:455—471, 1984
43. BURNS A, Li PK-T, REES AJ: The immunogenetics of glomerulo-
nephritis, in The Immunology of Rena! Disease, edited by PUSEY
CD, Lancaster, Kluwer, 1991, pp. 1—28
44. WHO NONMENCLATURE COMMITTEE: Nomenclature for factors of
the HLA system, 1991. Immunogenetics 36:135—148, 1992
45. NEPON GT, ERLICH H: MCH class-IL molecules and autoimmunity.
Annu Rev Immuno! 9:493—525, 1991
46. BJORKMAN PJ, SAPER MA, SAMRAOUI B, BENNETT WS,
STROMINGER JL, WILEY DC: Structure of the human class I
histocompatibility antigen, HLA-A2. Nature 329:506—512, 1987
Rees: Immunogenetics 383
47. BROWN JH, JARDETZKY TS, GORGA JC, STERN U, URBAN RG,
STROMINGER JL, WILEY DC: Three-dimensional structure of the
human class II histocompatibility antigen HLA-DR1. Nature 364:
33—39, 1993
48. FALK K, ROTZSCHKE 0, STEVANOVIC S, JUNG 0, RAMMENSEE
HG: Allele-specific motifs revealed by sequencing of seif-peptides
eluted from MHC molecules. Nature 351:290—296, 1991
49. HUNT DF, MICHEL H, DICKINSON TA, SHABANOWITZ J, Cox AL,
SAKAGUCHI K, APPELLA E, GREY HM, SETTE A: Peptides pre-
sented to the immune system by the murine class II major histo-
compatibility complex molecule 1-A". Science 256:1817—1820, 1992
50. CHICZ RM, URBAN RG, GORGA JC, VIGNALI AA, LANE WS,
STROMINGER JL: Specificity and promiscuity among naturally
processed peptides bound to HLA-DR alleles. J Exp Med 178:27—
47, 1993
51. TURNER N, REES AJ: Anti-glomerular basement membrane dis-
ease, in Oxford Textbook of Nephrology, edited by CAMERON JS,
DAVISON AM, GRUNFELD J-P, KERR DNS, RITZ E, Oxford,
Oxford University Press, 1991
52. SAUS J, WIESLANDER J, LANGEVELD JPM, QUINONES 5, HUDSON
BG: Identification of the Goodpasture antigen as the a3(IV) chain
of collagen IV. JBiol Chem 263:13374—13380, 1988
53. TURNER N, MASON PJ, BROWN R, Fox M, POVEY S, REES A,
PUSEY CD: Molecular cloning of the human Goodpasture antigen
demonstrates it to be the a3 chain of type IV collagen. J Cliii Invest
89:592—601, 1992
54. REES AJ, PETERS DK, COMPSTON DA, BATCHELOR JR: Strong
association between HLA-DRW2 and antibody-mediated Goodpas-
ture's syndrome. Lancet 1:966—968, 1978
55. REES AJ, PETERS DK, AMOS N, WELSH K, BATCHELOR JR
Separate HLA-linked genes influence susceptibility to anti-glomer-
ular basement membrane antibody-mediated nephritis and its se-
verity. Kidney Int 26:440—450, 1984
56. KLOUDA PT, MANOS J, ACHESON EJ, DYER PA, GOLDBY FS,
HARRIS R, LAWLER W, MALLICK NP, WILLIAMS G: Strong asso-
ciation between idiopathic membranous nephropathy and HLA-
DRW3. Lancet 2:770—771, 1979
57. Hw Y, KOBAYASHI Y, ITOH I, KASHIWAGI N: Strong association
of HLA-DR2 and MT1 with idiopathic membranous nephropathy in
Japan. Kidney Int 25:953—957, 1984
58. TOMURA 5, KASHIWABARA H, TUCHIDA J, SHISHIDO H, SAKURAI
S, TSuJI K, TAKEUCHI J: Strong association of idiopathic membra-
nous nephropathy with HLA-DR2 and MT1 in Japanese. Nephron
36:242—245, 1984
59. VAUGHAN RW, DEMAINE AG, WELSH KI: A DQA1 allele is
strongly associated with idiopathic membranous nephropathy. Tis-
sue Antigens 34:261—269, 1989
60. OGAHARA 5, MICHINAGA I, HIRATSUKA T, ABE K, NAITO S: DNA
typing of HLA class II genes in idiopathic nephropathy. Nippon
Rinsho 50:3072—3078, 1992
61. VAUGHAN RW, OGAHARA S, ACQUART S, PLEINDOUX MJ,
BERTHOUX P, BERTHOUX FC, LE PETIT JC, NAITO 5: Idiopathic
membranous nephropathy, in, Histocompatibilily Testing 1991,
edited by Tsuji, 1991, pp. 745—748
62. MooRE RH, HITMAN GA, LUCAS E, RICHARDS N, YENNING M,
PAPIHA 5, AWAD J, CUNNINGHAM J, MARSH FP: Genetic suscep-
tibility to autoimmunity in primary IgA nephropathy. (abstract)
Nephrol Dial Transplant 4:428—429, 1989
63. Li PK-T, BURNS AP, So AKL, PUSEY CD, FEEHALLY J, REES AJ:
The DQw7 allele at the HLA-DQB locus is associated with Suscep-
tibility to IgA nephropathy in Caucasians. Kidney Int 39:961—965,
1991
64. HIKI Y, KOBAYASHI Y, OOKUBO M, OBATA F, KASHIWAGI N:
Association of HLA-DQw4 with IgA nephropathy in the Japanese
population. Nephron 58:109—111, 1991
65. LI PK, BURNS A, LA! KN, So A, REE5 AJ: Famailial IgA
nephropathy: A study of HLA allogenotypes in a Chinese kindred.
Am J Kidney Dis 20:458—462, 1992
66. MOORE RH, HITMAN GA, MEDCRAFT J, Sn'uco RA, MUSTONEN J,
LUCAS EY, D'AMIco G: HLA-DP polymorphism in primary IgA
nephropathy: No association. Nephrol Dial Transplant 7:200—204,
1992
67. SPENCER SJW, BURNS A, GASKIN G, PUSEY CD, REES AJ: HLA
class II specificities and the development and duration of small
vessel vasculitis. Kidney Int 41:1059—1063, 1992
68. PAPPA H, HADJIYANNAKOS, SLAKATOS M, TARASSI K, NIKOLO-
POULOU N, MICHAEL 5, KAMANIS CH, VASNIDES G, BILLIS A,
PAPASTERIADES CH: HLA antigens and microscopic polyarteritis
with renal involvement: A protective role of HLA-DR3. Eighth
International Congress of Immunology Abstracts, p. 317
69. MULLER GA, GEBHARDT M, KOMPF J, BALDWIN WM, ZIEGEN-
HAGEN D, B0HLE A: Association between rapidly progressive
glomerulonephritis and the properdin factor BfF and different
HLA-D region products. Kidney Int 25:115—118, 1984
70. ELKON KB, SUTHERLAND DC, REES AJ, HUGHES GR, BATCHELOR
JR: HLA antigen frequencies in systemic vasculitis: Increase in
HLA-DR2 in Wegener's granulomatosis. Arthritis Rheum 26:98—
101, 1983
71. WooDRow JC: Immunogenetics of systemic lupus erythematosis. J
Rheumatol 15:197—199, 1988
72. DOHERTY DG, IRELAND R, DEMAINE AG, WANG F, VEERAPAN K,
WELSH KI, VERGANI D: Major histocompatibility complex genes
and susceptibility to systemic lupus erythematosus in Southern
Chinese. Arthritis Rheum 35:641—646, 1992
73. ARNETI FC: Genetic aspects of human lupus. Clin Immunol
Immunopathol 63:4-6, 1992
74. REVEILLE JD, MACLEOn MJ, WHITFINGTON K, ARNE'n FC:
Specific amino acid residues in the second hypervariable region of
HLA-DQAI and DQB1 chain genes promote the Ro(SS-A)/La
(SS-B) autoantibody responses. J Immunol 146:3871—3876, 1991
75. MORGAN BP, WALPORT MJ: Complement deficiency and disease.
Immunol Today 12:301—306, 1991
76. GLASS D, RAUM D, GIBSON D, STILLMAN JS, SCHUR PH: Inherited
deficiency of the second component of complement: rheumatic
disease association. J Clin Invest 58:853—861, 1976
77. FIELDER AH, WALPORT MJ, BATCHELOR JR: Family study of the
MHC in patients with SUE: Importance of null alleles in C4A and
C4B in determining disease susceptibility. Br J Med 286:425—428,
1983
78. CHR1STIANSEN Fr, MCCLUSKEY J, DAWIUNS RL, K,&y PH, UKO
G, ZILKO PJ: Complement allotyping in SLE: association with C4A
null. Aust NZ J Med 13:483—488, 1983
79, REVEILLE JD, ARNETI FC, WILSON RW, BIAS WB, MCLEAN RH:
Null alleles of the fourth component of complement and HLA
haplotypes in familial systemic lupus erythematosus. Immunoge-
netics 21:299—311, 1985
80. HOWARD PF, HOCHBERG MC, BIAS WB, ARNETT FC, MCLEAN
RH: Relationship between C4 null genes, LA-D region antigens,
and genetic susceptibility to systemic lupus erythematosus in
Caucasoid and Black Americans. Am J Med 81:187—193, 1986
81. KEMP ME, ATKINSON PJ, SKANES VM, LEVINE RP, CHAPLIN DD:
Deletion of C4A genes in patients with systemic lupus erythema-
tosus. Arthritis Rheum 30:1015—1022, 1987
82. BATCHELOR JR, FIELDER AHL, WALPORT MJ: Family study of the
major histocompatibility complex in HLA-DR3 negative patients
with systemic lupus erythematosus. Clin Exp Immunol 70:364—371,
1987
